vs
Side-by-side financial comparison of BYLINE BANCORP, INC. (BY) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.
iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $112.4M, roughly 1.9× BYLINE BANCORP, INC.). BYLINE BANCORP, INC. runs the higher net margin — 33.4% vs 2.7%, a 30.8% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 9.0%). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 6.4%).
Byline Bank is a bank headquartered in Chicago, Illinois, United States. It is the primary subsidiary of Byline Bancorp, Inc., a bank holding company, and the 4th largest SBA 7(a) lender.
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
BY vs IRTC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $112.4M | $208.9M |
| Net Profit | $37.6M | $5.6M |
| Gross Margin | — | 70.9% |
| Operating Margin | — | 1.1% |
| Net Margin | 33.4% | 2.7% |
| Revenue YoY | 9.0% | 27.1% |
| Net Profit YoY | 33.0% | 518.5% |
| EPS (diluted) | $0.83 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $112.4M | — | ||
| Q4 25 | $117.0M | $208.9M | ||
| Q3 25 | $115.7M | $192.9M | ||
| Q2 25 | $110.5M | $186.7M | ||
| Q1 25 | $103.1M | $158.7M | ||
| Q4 24 | $104.7M | $164.3M | ||
| Q3 24 | $101.8M | $147.5M | ||
| Q2 24 | $99.4M | $148.0M |
| Q1 26 | $37.6M | — | ||
| Q4 25 | $34.5M | $5.6M | ||
| Q3 25 | $37.2M | $-5.2M | ||
| Q2 25 | $30.1M | $-14.2M | ||
| Q1 25 | $28.2M | $-30.7M | ||
| Q4 24 | $30.3M | $-1.3M | ||
| Q3 24 | $30.3M | $-46.2M | ||
| Q2 24 | $29.7M | $-20.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | 70.9% | ||
| Q3 25 | — | 71.1% | ||
| Q2 25 | — | 71.2% | ||
| Q1 25 | — | 68.8% | ||
| Q4 24 | — | 70.0% | ||
| Q3 24 | — | 68.8% | ||
| Q2 24 | — | 69.9% |
| Q1 26 | — | — | ||
| Q4 25 | 40.1% | 1.1% | ||
| Q3 25 | 43.1% | -4.4% | ||
| Q2 25 | 35.2% | -10.0% | ||
| Q1 25 | 36.4% | -20.5% | ||
| Q4 24 | 38.6% | -2.5% | ||
| Q3 24 | 39.3% | -34.1% | ||
| Q2 24 | 40.4% | -15.5% |
| Q1 26 | 33.4% | — | ||
| Q4 25 | 34.1% | 2.7% | ||
| Q3 25 | 32.1% | -2.7% | ||
| Q2 25 | 27.2% | -7.6% | ||
| Q1 25 | 27.4% | -19.3% | ||
| Q4 24 | 34.3% | -0.8% | ||
| Q3 24 | 29.8% | -31.3% | ||
| Q2 24 | 29.9% | -13.6% |
| Q1 26 | $0.83 | — | ||
| Q4 25 | $0.77 | $0.18 | ||
| Q3 25 | $0.82 | $-0.16 | ||
| Q2 25 | $0.66 | $-0.44 | ||
| Q1 25 | $0.64 | $-0.97 | ||
| Q4 24 | $0.68 | $-0.03 | ||
| Q3 24 | $0.69 | $-1.48 | ||
| Q2 24 | $0.68 | $-0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $198.4M | $583.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $152.7M |
| Total Assets | $9.9B | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $198.4M | — | ||
| Q4 25 | $149.1M | $583.8M | ||
| Q3 25 | $259.0M | $565.2M | ||
| Q2 25 | $218.3M | $545.5M | ||
| Q1 25 | $421.3M | $520.6M | ||
| Q4 24 | $563.1M | $535.6M | ||
| Q3 24 | $452.6M | $522.0M | ||
| Q2 24 | $730.5M | $561.5M |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $152.7M | ||
| Q3 25 | $1.2B | $121.9M | ||
| Q2 25 | $1.2B | $103.7M | ||
| Q1 25 | $1.1B | $86.7M | ||
| Q4 24 | $1.1B | $90.9M | ||
| Q3 24 | $1.1B | $71.8M | ||
| Q2 24 | $1.0B | $99.2M |
| Q1 26 | $9.9B | — | ||
| Q4 25 | $9.7B | $1.0B | ||
| Q3 25 | $9.8B | $995.2M | ||
| Q2 25 | $9.7B | $964.0M | ||
| Q1 25 | $9.6B | $926.1M | ||
| Q4 24 | $9.5B | $931.4M | ||
| Q3 24 | $9.4B | $909.7M | ||
| Q2 24 | $9.6B | $919.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $26.2M |
| Free Cash FlowOCF − Capex | — | $14.5M |
| FCF MarginFCF / Revenue | — | 6.9% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | — | 4.70× |
| TTM Free Cash FlowTrailing 4 quarters | — | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $140.3M | $26.2M | ||
| Q3 25 | $38.3M | $34.9M | ||
| Q2 25 | $16.3M | $27.7M | ||
| Q1 25 | $27.1M | $-7.9M | ||
| Q4 24 | $175.2M | $19.2M | ||
| Q3 24 | $19.8M | $24.3M | ||
| Q2 24 | $40.1M | $11.8M |
| Q1 26 | — | — | ||
| Q4 25 | $136.3M | $14.5M | ||
| Q3 25 | $38.0M | $20.1M | ||
| Q2 25 | $15.2M | $17.3M | ||
| Q1 25 | $25.0M | $-17.3M | ||
| Q4 24 | $171.2M | $12.4M | ||
| Q3 24 | $19.1M | $15.5M | ||
| Q2 24 | $39.4M | $3.4M |
| Q1 26 | — | — | ||
| Q4 25 | 116.5% | 6.9% | ||
| Q3 25 | 32.8% | 10.4% | ||
| Q2 25 | 13.7% | 9.3% | ||
| Q1 25 | 24.3% | -10.9% | ||
| Q4 24 | 163.5% | 7.5% | ||
| Q3 24 | 18.8% | 10.5% | ||
| Q2 24 | 39.7% | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | 3.4% | 5.6% | ||
| Q3 25 | 0.3% | 7.7% | ||
| Q2 25 | 1.0% | 5.6% | ||
| Q1 25 | 2.0% | 5.9% | ||
| Q4 24 | 3.8% | 4.2% | ||
| Q3 24 | 0.6% | 6.0% | ||
| Q2 24 | 0.7% | 5.7% |
| Q1 26 | — | — | ||
| Q4 25 | 4.06× | 4.70× | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 0.54× | — | ||
| Q1 25 | 0.96× | — | ||
| Q4 24 | 5.78× | — | ||
| Q3 24 | 0.65× | — | ||
| Q2 24 | 1.35× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BY
Segment breakdown not available.
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
